Interestingly, the density and incidence of NTS1R expression was found to increase in advanced and androgen-independent stages of prostate cancer [30,32,33], whereas GRPR-expression is more prominent in the early stages of the disease [7,16,34,35]. Here, GRPR is linked to prostate carcinoma.